GLS and cancer: It was reported that N-terminal phosphorylation of glutaminase C (GAC) at serine 95 decreases its enzymatic activity and cancer cell migration [17] while phosphorylation on GAC’s serine 314 catalyzed by PKCε leads to protein activation and an elevation of glutaminase activity and tumor malignancy [18].